However, related clinical analyses have shown that statin therapy might induce an overt primary hypogonadism in adult males, causing decreased testosterone levels associated with down regulation of penile RhoA/Rho-kinase (ROCK) signaling47, 48. This evidence concerns the gene RHOA and Hypergonadotropic hypogonadism.